JP2014041142A - 物質の混合物を分析する質量分析方法 - Google Patents
物質の混合物を分析する質量分析方法 Download PDFInfo
- Publication number
- JP2014041142A JP2014041142A JP2013213955A JP2013213955A JP2014041142A JP 2014041142 A JP2014041142 A JP 2014041142A JP 2013213955 A JP2013213955 A JP 2013213955A JP 2013213955 A JP2013213955 A JP 2013213955A JP 2014041142 A JP2014041142 A JP 2014041142A
- Authority
- JP
- Japan
- Prior art keywords
- mass
- substance mixture
- ions
- ionization
- analysis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 112
- 239000000126 substance Substances 0.000 title claims abstract description 96
- 239000000203 mixture Substances 0.000 title claims abstract description 78
- 238000004949 mass spectrometry Methods 0.000 title claims description 17
- 150000002500 ions Chemical class 0.000 claims abstract description 89
- 238000004458 analytical method Methods 0.000 claims abstract description 48
- 230000001133 acceleration Effects 0.000 claims abstract description 7
- 238000013467 fragmentation Methods 0.000 claims description 15
- 238000006062 fragmentation reaction Methods 0.000 claims description 15
- 230000005684 electric field Effects 0.000 claims description 12
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 8
- 238000013375 chromatographic separation Methods 0.000 claims description 7
- 238000013537 high throughput screening Methods 0.000 claims description 7
- 238000000926 separation method Methods 0.000 claims description 5
- 238000001704 evaporation Methods 0.000 claims description 3
- 238000011144 upstream manufacturing Methods 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 abstract description 17
- 230000008569 process Effects 0.000 abstract description 14
- 239000007789 gas Substances 0.000 description 25
- 238000002552 multiple reaction monitoring Methods 0.000 description 24
- 238000002474 experimental method Methods 0.000 description 20
- 239000002904 solvent Substances 0.000 description 18
- 239000000523 sample Substances 0.000 description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 13
- 238000001514 detection method Methods 0.000 description 13
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 11
- 239000000872 buffer Substances 0.000 description 8
- 238000004587 chromatography analysis Methods 0.000 description 8
- 238000000752 ionisation method Methods 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- 238000011002 quantification Methods 0.000 description 7
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 229910052786 argon Inorganic materials 0.000 description 6
- 238000000065 atmospheric pressure chemical ionisation Methods 0.000 description 6
- 238000000132 electrospray ionisation Methods 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 239000002207 metabolite Substances 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 238000002703 mutagenesis Methods 0.000 description 5
- 231100000350 mutagenesis Toxicity 0.000 description 5
- 239000000419 plant extract Substances 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 230000007704 transition Effects 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- -1 argon ions Chemical class 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000005251 capillar electrophoresis Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 238000004817 gas chromatography Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- VYIRVAXUEZSDNC-TXDLOWMYSA-N (3R,3'S,5'R)-3,3'-dihydroxy-beta-kappa-caroten-6'-one Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC(=O)[C@]1(C)C[C@@H](O)CC1(C)C VYIRVAXUEZSDNC-TXDLOWMYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- RAFGELQLHMBRHD-VFYVRILKSA-N Bixin Natural products COC(=O)C=CC(=C/C=C/C(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)O)/C)C RAFGELQLHMBRHD-VFYVRILKSA-N 0.000 description 2
- VYIRVAXUEZSDNC-LOFNIBRQSA-N Capsanthyn Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC(=O)C2(C)CC(O)CC2(C)C VYIRVAXUEZSDNC-LOFNIBRQSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- RAFGELQLHMBRHD-UHFFFAOYSA-N alpha-Fuc-(1-2)-beta-Gal-(1-3)-(beta-GlcNAc-(1-6))-GalNAc-ol Natural products COC(=O)C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC(O)=O RAFGELQLHMBRHD-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000001670 anatto Substances 0.000 description 2
- 235000012665 annatto Nutrition 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- RAFGELQLHMBRHD-SLEZCNMESA-N bixin Chemical compound COC(=O)\C=C\C(\C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C(O)=O RAFGELQLHMBRHD-SLEZCNMESA-N 0.000 description 2
- WRANYHFEXGNSND-LOFNIBRQSA-N capsanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC(=O)C2(C)CCC(O)C2(C)C WRANYHFEXGNSND-LOFNIBRQSA-N 0.000 description 2
- 235000018889 capsanthin Nutrition 0.000 description 2
- 238000000451 chemical ionisation Methods 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- 235000017471 coenzyme Q10 Nutrition 0.000 description 2
- 229940110767 coenzyme Q10 Drugs 0.000 description 2
- 238000001212 derivatisation Methods 0.000 description 2
- 238000004807 desolvation Methods 0.000 description 2
- 238000003795 desorption Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000004880 explosion Methods 0.000 description 2
- 238000010265 fast atom bombardment Methods 0.000 description 2
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000001307 helium Substances 0.000 description 2
- 229910052734 helium Inorganic materials 0.000 description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000005040 ion trap Methods 0.000 description 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000012454 non-polar solvent Substances 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Polymers 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 235000012658 paprika extract Nutrition 0.000 description 2
- 239000001688 paprika extract Substances 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- OGYGFHBNULOMHN-KODRXGBYSA-N (3r,4s,5r)-3,4,5,6-tetrahydroxyhexanamide Chemical compound NC(=O)C[C@@H](O)[C@H](O)[C@H](O)CO OGYGFHBNULOMHN-KODRXGBYSA-N 0.000 description 1
- VILCJCGEZXAXTO-UHFFFAOYSA-N 2,2,2-tetramine Chemical compound NCCNCCNCCN VILCJCGEZXAXTO-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- PUKLDDOGISCFCP-JSQCKWNTSA-N 21-Deoxycortisone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2=O PUKLDDOGISCFCP-JSQCKWNTSA-N 0.000 description 1
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 1
- QJZYHAIUNVAGQP-UHFFFAOYSA-N 3-nitrobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical compound C1C2C=CC1C(C(=O)O)C2(C(O)=O)[N+]([O-])=O QJZYHAIUNVAGQP-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- FCYKAQOGGFGCMD-UHFFFAOYSA-N Fulvic acid Natural products O1C2=CC(O)=C(O)C(C(O)=O)=C2C(=O)C2=C1CC(C)(O)OC2 FCYKAQOGGFGCMD-UHFFFAOYSA-N 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000010564 aerobic fermentation Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 229910001413 alkali metal ion Inorganic materials 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 235000010633 broth Nutrition 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 150000001793 charged compounds Chemical class 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000011280 coal tar Substances 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 230000005686 electrostatic field Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000000105 evaporative light scattering detection Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 229940095100 fulvic acid Drugs 0.000 description 1
- 239000002509 fulvic acid Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000004021 humic acid Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000001282 iso-butane Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000002829 nitrogen Chemical class 0.000 description 1
- 229910052756 noble gas Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000003608 radiolysis reaction Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 238000009751 slip forming Methods 0.000 description 1
- 238000000935 solvent evaporation Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000010972 statistical evaluation Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Images
Classifications
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J49/00—Particle spectrometers or separator tubes
- H01J49/004—Combinations of spectrometers, tandem spectrometers, e.g. MS/MS, MSn
- H01J49/0045—Combinations of spectrometers, tandem spectrometers, e.g. MS/MS, MSn characterised by the fragmentation or other specific reaction
- H01J49/005—Combinations of spectrometers, tandem spectrometers, e.g. MS/MS, MSn characterised by the fragmentation or other specific reaction by collision with gas, e.g. by introducing gas or by accelerating ions with an electric field
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J49/00—Particle spectrometers or separator tubes
- H01J49/26—Mass spectrometers or separator tubes
- H01J49/34—Dynamic spectrometers
- H01J49/42—Stability-of-path spectrometers, e.g. monopole, quadrupole, multipole, farvitrons
- H01J49/4205—Device types
- H01J49/421—Mass filters, i.e. deviating unwanted ions without trapping
Landscapes
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Electron Tubes For Measurement (AREA)
Abstract
【解決手段】3連4重極質量分析器を用いて、a)質量分析器の第1分析用4重極におけるイオン化によって形成されたイオンの質量/電荷比(m/z)を選択するステップと、b)衝突ガスで満たされ、衝突室として働く後続の追加の4重極において加速電圧を印加することによって、ステップ(a)で選択されたイオンを断片化するステップと、c)下流の別の追加の4重極において、ステップ(b)の断片化プロセスによって生成されたイオンの質量/電荷比を選択するステップとを含み、この方法ステップ(a)〜(c)を少なくとも1回実施し、この方法がさらに、(d)イオン化した結果として物質混合物中に存在するすべてのイオンの質量/電荷比を分析するステップをさらに含み、分析中に、後続の追加の4重極は衝突ガスで満たされているが、加速電圧は印加されないことを特徴とする。
【選択図】図1
Description
a)質量分析器の第1分析用4重極(I)におけるイオン化によって形成されたイオンの質量/電荷比(m/z)を選択するステップと、
b)衝突ガスで満たされ、衝突室として機能する後続の別の4重極(II)において加速電圧を印加することによって、ステップ(a)で選択されたイオンを断片化するステップと、
c)さらに下流の4重極(III)において、断片化ステップ(b)によって形成されたイオンの質量/電荷比を選択するステップであって、これらの方法ステップ(a)〜(c)を少なくとも1回実施するステップと、
d)イオン化の結果として物質混合物中に存在するすべてのイオンの質量/電荷比を分析するステップであって、分析中に、4重極(II)は衝突ガスで満たされているが、加速電圧は印加されないステップ
ステップ(a)〜(c)およびステップ(d)は、逆の順序で実行することもできる。
a)MRM+FS分析のTIC
図2に、MRM+フル・スキャン分析の全イオン・クロマトグラムを示す(ただし、MRMは複数反応モニタリング、FSはフル・スキャン、TICは全イオン・クロマトグラム、XITは複数の全イオン・クロマトグラムの合計である)。品質管理サンプルを分析した。このタイプのサンプルは、規定数の検出物を含む。これらの検出物は市販品であり、それらを既知濃度の適切な溶媒に溶解させた。
図3に、MRM+FS分析からのMRM実験の全イオン・クロマトグラムを示す。
図5のTICに、MRM実験に変えて測定したFS実験を示す。
図2の場合と同様に、図8に、MRM+フル・スキャン分析の全イオン・クロマトグラムを示す。較正サンプルを分析した。
Claims (14)
- 3連4重極質量分析器を用いて物質混合物を分析する質量分析方法であって、前記物質混合物が前記分析の前にイオン化され、前記方法が、
a)前記質量分析器の第1分析用4重極(I)において、イオン化によって形成されたイオンの質量/電荷比(m/z)を選択するステップと、
b)衝突ガスで満たされ、衝突室として機能する後続の別の4重極(II)において加速電圧を印加することによって、ステップ(a)で選択された前記イオンを断片化する断片化ステップと、
c)下流の別の4重極(III)において、前記断片化ステップ(b)によって形成されたイオンの質量/電荷比を選択するステップと、
d)前記イオン化の結果として前記物質混合物中に存在するすべてのイオンの前記質量/電荷比を分析するステップであって、分析中に、前記4重極(II)は衝突ガスで満たされているが、加速電圧は印加されないステップと、
を含み、
前記ステップ(a)〜(d)は、ステップ(a)、(b)、(c)及び(d)の順番か、またはステップ(d)、(a)、(b)及び(c)の順番で実行され、前記方法ステップ(a)〜(c)は少なくとも1回実施される、方法。 - ステップ(a)〜(d)を、0.1〜10秒以内で少なくとも1回実施する、請求項1に記載の方法。
- ステップ(a)〜(d)を、0.2〜2秒以内で少なくとも1回実施する、請求項1または2に記載の方法。
- 前記物質混合物を蒸発させ、気相中でイオン化することによって、前記物質混合物を表面上で脱離することによって、または前記物質混合物を電界中で霧化することによって前記イオン化を実施する、請求項1から3のいずれか一項に記載の方法。
- 前記物質混合物を電界中で霧化することによって前記イオン化を実施する、請求項1から4のいずれか一項に記載の方法。
- ステップ(a)で、イオン化によって形成され選択された異なるイオンのうち、質量/電荷比が1〜100のものを分析する、請求項1から5のいずれか一項に記載の方法。
- 前記物質混合物が生物または化学起源のものである、請求項1から6のいずれか一項に記載の方法。
- 手作業で実施されるか、あるいは自動的に実施される、請求項1から7のいずれか一項に記載の方法。
- ハイ・スループット・スクリーニングで用いられる、請求項1から8のいずれか一項に記載の方法。
- 前記物質混合物中に存在するすべてのイオンについて、ステップ(c)で分析される前記断片化ステップ(b)によって形成されたイオンおよびステップ(d)で分析される前記質量/電荷比(m/z)、または、前記物質混合物中に存在するすべてのイオンについて、ステップ(c)で分析される前記断片化ステップ(b)によって形成されたイオン若しくはステップ(d)で分析される前記質量/電荷比(m/z)を定量化する、請求項1から9のいずれか一項に記載の方法。
- 前記物質混合物の前記イオン化が、クロマトグラフィー分離の上流で行われる、請求項1から10のいずれか一項に記載の方法。
- 前記クロマトグラフィー分離がHPLC分離である、請求項11に記載の方法。
- 前記分析の前に前記物質混合物が誘導体化される、請求項1から10のいずれか一項に記載の方法。
- 前記クロマトグラフィー分離の前に前記物質混合物が誘導体化される、請求項11または12に記載の方法。
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10208625.7 | 2002-02-28 | ||
| DE10208626.5 | 2002-02-28 | ||
| DE2002108625 DE10208625A1 (de) | 2002-02-28 | 2002-02-28 | Massenspektrometrisches Verfahren zur Analyse von Substanzgemischen |
| DE2002108626 DE10208626A1 (de) | 2002-02-28 | 2002-02-28 | Massenspektrometrisches Verfahren zur Analyse von Substanzgemischen |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009218884A Division JP2010019848A (ja) | 2002-02-28 | 2009-09-24 | 物質の混合物を分析する質量分析方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2014041142A true JP2014041142A (ja) | 2014-03-06 |
Family
ID=27766685
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003572064A Pending JP2005526962A (ja) | 2002-02-28 | 2003-02-10 | 物質の混合物を分析する質量分析方法 |
| JP2009218884A Pending JP2010019848A (ja) | 2002-02-28 | 2009-09-24 | 物質の混合物を分析する質量分析方法 |
| JP2013213955A Pending JP2014041142A (ja) | 2002-02-28 | 2013-10-11 | 物質の混合物を分析する質量分析方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003572064A Pending JP2005526962A (ja) | 2002-02-28 | 2003-02-10 | 物質の混合物を分析する質量分析方法 |
| JP2009218884A Pending JP2010019848A (ja) | 2002-02-28 | 2009-09-24 | 物質の混合物を分析する質量分析方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7196323B2 (ja) |
| EP (1) | EP1481416B1 (ja) |
| JP (3) | JP2005526962A (ja) |
| AU (1) | AU2003218649B2 (ja) |
| CA (1) | CA2476597C (ja) |
| ES (1) | ES2590759T3 (ja) |
| IL (1) | IL163290A (ja) |
| NO (1) | NO20043943L (ja) |
| WO (1) | WO2003073464A1 (ja) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2018081023A (ja) * | 2016-11-17 | 2018-05-24 | 学校法人東京理科大学 | ビタミンdの定量方法、質量分析装置およびビタミンd定量用試薬キット |
| WO2018181320A1 (ja) * | 2017-03-29 | 2018-10-04 | 一般財団法人石油エネルギー技術センター | 多成分混合物の分子構造を近似的に特定する方法及びプログラム |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004034011A2 (en) * | 2002-10-10 | 2004-04-22 | Universita' Degli Studi Di Milano | Ionization source for mass spectrometry analysis |
| US8190375B2 (en) | 2005-07-08 | 2012-05-29 | Metanomics Gmbh | System and method for characterizing a chemical sample |
| AU2006274029B2 (en) * | 2005-07-25 | 2011-07-14 | Metanomics Gmbh | Means and methods for analyzing a sample by means of chromatography-mass spectrometry |
| CA2647122A1 (en) | 2006-03-24 | 2007-10-04 | Metanomics Gmbh | Means and method for diagnosing diabetes |
| US20090194679A1 (en) * | 2008-01-31 | 2009-08-06 | Agilent Technologies, Inc. | Methods and apparatus for reducing noise in mass spectrometry |
| US20110113863A1 (en) * | 2008-07-15 | 2011-05-19 | Metanomics Health Gmbh | Means and methods diagnosing gastric bypass and conditions related thereto |
| EP2350287A2 (en) | 2008-10-23 | 2011-08-03 | BASF Plant Science GmbH | A method for producing a transgenic cell with increased gamma-aminobutyric acid (gaba) content |
| US9274248B2 (en) * | 2009-01-21 | 2016-03-01 | Schlumberger Technology Corporation | Downhole mass spectrometry |
| EP2804001B1 (en) | 2009-06-04 | 2017-08-09 | Metanomics Health GmbH | Methods for diagnosing prostate carcinomas |
| AU2010326737A1 (en) | 2009-12-01 | 2012-06-07 | Metanomics Health Gmbh | Means and methods for diagnosing multiple sclerosis |
| WO2011092285A2 (en) | 2010-01-29 | 2011-08-04 | Metanomics Gmbh | Means and methods for diagnosing heart failure in a subject |
| EP3355057A3 (en) | 2010-06-01 | 2018-12-12 | Metanomics Health GmbH | Means and methods for diagnosing pancreatic cancer in a subject |
| EP2863227B1 (en) | 2010-06-10 | 2017-09-27 | Metanomics Health GmbH | Means and methods for metabolic differentiation of non-alcoholic steatohepatitis from liver disease |
| CN103392219B (zh) | 2010-12-28 | 2017-02-08 | 探索诊断投资公司 | 通过质谱法定量胰岛素 |
| CA2834455A1 (en) | 2011-05-31 | 2012-12-06 | Metanomics Health Gmbh | Methods for diagnosing multiple sclerosis |
| EP3527990A1 (en) | 2011-07-28 | 2019-08-21 | metanomics GmbH | Use of sm_sphingomyelin (d18:1, c23:1) as a marker for heart failure |
| AU2012343843B2 (en) | 2011-11-30 | 2018-03-08 | Metanomics Health Gmbh | Device and methods to diagnose pancreatic cancer |
| US20150044702A1 (en) * | 2012-03-09 | 2015-02-12 | Basf Se | Means and methods for assessing disorders related to impaired iron adsorption or energy metabolism |
| CA2864471A1 (en) * | 2012-03-09 | 2013-09-12 | Basf Se | Means and methods for assessing liver disorders |
| WO2014053564A1 (en) | 2012-10-02 | 2014-04-10 | Metanomics Health Gmbh | Means and methods for diagnosing recurrence of prostate cancer after prostatectomy |
| EP2909626B1 (en) | 2012-10-18 | 2018-07-04 | metanomics GmbH | Means and methods for determining a clearance normalized amount of a metabolite disease biomarker in a sample |
| KR101590573B1 (ko) * | 2013-07-31 | 2016-02-01 | 주식회사 엘지화학 | 순물질 조합을 이용한 혼합물의 특성 평가 방법 및 이를 이용한 시스템 |
| CA2934012A1 (en) | 2013-12-20 | 2015-06-25 | Metanomics Health Gmbh | Means and methods for diagnosing pancreatic cancer in a subject based on a metabolite panel |
| GB2531336B (en) | 2014-10-17 | 2019-04-10 | Thermo Fisher Scient Bremen Gmbh | Method and apparatus for the analysis of molecules using mass spectrometry and optical spectroscopy |
| US10324082B2 (en) | 2015-03-03 | 2019-06-18 | Quest Diagnostics Investments Llc | Methods for quantitation of insulin levels by mass spectrometry |
| RU2613897C1 (ru) * | 2015-12-21 | 2017-03-21 | Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский Томский политехнический университет" | Вольтамперометрический способ определения коэнзима q10 в кремах косметических |
| WO2017149603A1 (ja) * | 2016-02-29 | 2017-09-08 | 株式会社島津製作所 | 質量分析装置 |
| WO2018007394A1 (en) | 2016-07-08 | 2018-01-11 | Basf Plant Science Company Gmbh | Method for the calibration of a biological sample |
| EP4617668A3 (en) | 2017-03-31 | 2025-12-24 | Quest Diagnostics Investments LLC | Methods for quantitation of insulin and c-peptide |
| JP7090863B2 (ja) * | 2017-06-30 | 2022-06-27 | 株式会社サンセイアールアンドディ | 遊技機 |
| EP3502699A1 (en) | 2017-12-20 | 2019-06-26 | Metanomics Health GmbH | Methods for diagnosing pancreatic cancer |
| EP3502703A1 (en) | 2017-12-22 | 2019-06-26 | Metanomics Health GmbH | Method for the assessment of nafld |
| EP3696822A1 (en) | 2019-02-18 | 2020-08-19 | Metanomics Health GmbH | Means and methods for determining a personalized cutoff value for a biomarker |
| JP2024516678A (ja) | 2021-04-30 | 2024-04-16 | エフ. ホフマン-ラ ロシュ アーゲー | 敗血症の早期検出用のstrem1マーカーパネル |
| JP2024515086A (ja) | 2021-04-30 | 2024-04-04 | エフ. ホフマン-ラ ロシュ アーゲー | 敗血症の早期検出のためのgdf15マーカーパネル |
| CN117321419A (zh) | 2021-04-30 | 2023-12-29 | 豪夫迈·罗氏有限公司 | 用于脓毒症的早期检测的Presepsin标志物组 |
| JP2024516680A (ja) | 2021-04-30 | 2024-04-16 | エフ. ホフマン-ラ ロシュ アーゲー | 敗血症の早期検出用のil6マーカーパネル |
| CN117242349A (zh) | 2021-04-30 | 2023-12-15 | 豪夫迈·罗氏有限公司 | 用于脓毒症的早期检测的igfbp7标志物组 |
| CN117295950A (zh) | 2021-04-30 | 2023-12-26 | 豪夫迈·罗氏有限公司 | 用于脓毒症的早期检测的ngal标志物组 |
| US20240230676A1 (en) | 2021-04-30 | 2024-07-11 | Roche Diagnostics Operations, Inc. | Esm1 marker panels for early detection of sepsis |
| JP2024516681A (ja) | 2021-04-30 | 2024-04-16 | エフ. ホフマン-ラ ロシュ アーゲー | 敗血症の早期検出のためのsFlt1マーカーパネル |
| JP7787908B2 (ja) | 2021-04-30 | 2025-12-17 | エフ. ホフマン-ラ ロシュ アーゲー | 敗血症の早期検出用のpctマーカーパネル |
| JP2024537774A (ja) | 2021-09-29 | 2024-10-16 | エフ. ホフマン-ラ ロシュ アーゲー | 敗血症の早期検出のためのMR-proADMマーカーパネル |
| EP4483186A1 (en) | 2022-02-21 | 2025-01-01 | F. Hoffmann-La Roche AG | Dll1 marker panels for early detection of sepsis |
| US20250362308A1 (en) | 2022-03-18 | 2025-11-27 | Roche Diagnostics Operations, Inc. | Tropnin marker combinations for early discrimination of type 2 versus type 1 acute myocardial infarction |
| EP4493937B1 (en) | 2022-03-18 | 2026-01-28 | F. Hoffmann-La Roche AG | Cmybpc marker combinations for early discrimination of type 2 versus type 1 acute myocardial infarction |
| WO2025080523A1 (en) * | 2023-10-11 | 2025-04-17 | Quest Diagnostics Investments Llc | Methods for the simultaneous detection and quantification of insulin, proinsulin, proinsulin metabolic intermediates, c-peptide, and c-peptide variants by mass spectrometry |
| WO2025196142A1 (en) | 2024-03-20 | 2025-09-25 | Roche Diagnostics International Ag | Myl7 or a fragment thereof for the assessment of atrial heart muscle tissue damage |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000048004A1 (en) * | 1999-02-11 | 2000-08-17 | Maxygen, Inc. | High throughput mass spectrometry |
| WO2001015201A2 (en) * | 1999-08-26 | 2001-03-01 | University Of New Hampshire | Multiple stage mass spectrometer |
| WO2001094941A2 (en) * | 2000-06-07 | 2001-12-13 | Univ Duke | Diagnostic methods for pompe disease and other glycogen storage diseases |
| WO2002008767A2 (en) * | 2000-07-25 | 2002-01-31 | The Procter & Gamble Company | Methods and kits for sequencing polypeptides |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4540884A (en) * | 1982-12-29 | 1985-09-10 | Finnigan Corporation | Method of mass analyzing a sample by use of a quadrupole ion trap |
| US5397894A (en) * | 1993-05-28 | 1995-03-14 | Varian Associates, Inc. | Method of high mass resolution scanning of an ion trap mass spectrometer |
| US6093929A (en) * | 1997-05-16 | 2000-07-25 | Mds Inc. | High pressure MS/MS system |
| US6140638A (en) * | 1997-06-04 | 2000-10-31 | Mds Inc. | Bandpass reactive collision cell |
| US6331702B1 (en) * | 1999-01-25 | 2001-12-18 | University Of Manitoba | Spectrometer provided with pulsed ion source and transmission device to damp ion motion and method of use |
| US6428956B1 (en) * | 1998-03-02 | 2002-08-06 | Isis Pharmaceuticals, Inc. | Mass spectrometric methods for biomolecular screening |
| US6504148B1 (en) * | 1999-05-27 | 2003-01-07 | Mds Inc. | Quadrupole mass spectrometer with ION traps to enhance sensitivity |
| US6586727B2 (en) * | 2000-06-09 | 2003-07-01 | Micromass Limited | Methods and apparatus for mass spectrometry |
| CA2340150C (en) * | 2000-06-09 | 2005-11-22 | Micromass Limited | Methods and apparatus for mass spectrometry |
| US7034292B1 (en) * | 2002-05-31 | 2006-04-25 | Analytica Of Branford, Inc. | Mass spectrometry with segmented RF multiple ion guides in various pressure regions |
-
2003
- 2003-02-10 US US10/505,154 patent/US7196323B2/en not_active Expired - Lifetime
- 2003-02-10 EP EP03711878.3A patent/EP1481416B1/de not_active Expired - Lifetime
- 2003-02-10 CA CA2476597A patent/CA2476597C/en not_active Expired - Fee Related
- 2003-02-10 ES ES03711878.3T patent/ES2590759T3/es not_active Expired - Lifetime
- 2003-02-10 AU AU2003218649A patent/AU2003218649B2/en not_active Ceased
- 2003-02-10 WO PCT/EP2003/001274 patent/WO2003073464A1/de not_active Ceased
- 2003-02-10 JP JP2003572064A patent/JP2005526962A/ja active Pending
-
2004
- 2004-07-29 IL IL163290A patent/IL163290A/en not_active IP Right Cessation
- 2004-09-21 NO NO20043943A patent/NO20043943L/no not_active Application Discontinuation
-
2009
- 2009-09-24 JP JP2009218884A patent/JP2010019848A/ja active Pending
-
2013
- 2013-10-11 JP JP2013213955A patent/JP2014041142A/ja active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000048004A1 (en) * | 1999-02-11 | 2000-08-17 | Maxygen, Inc. | High throughput mass spectrometry |
| WO2001015201A2 (en) * | 1999-08-26 | 2001-03-01 | University Of New Hampshire | Multiple stage mass spectrometer |
| WO2001094941A2 (en) * | 2000-06-07 | 2001-12-13 | Univ Duke | Diagnostic methods for pompe disease and other glycogen storage diseases |
| WO2002008767A2 (en) * | 2000-07-25 | 2002-01-31 | The Procter & Gamble Company | Methods and kits for sequencing polypeptides |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2018081023A (ja) * | 2016-11-17 | 2018-05-24 | 学校法人東京理科大学 | ビタミンdの定量方法、質量分析装置およびビタミンd定量用試薬キット |
| WO2018181320A1 (ja) * | 2017-03-29 | 2018-10-04 | 一般財団法人石油エネルギー技術センター | 多成分混合物の分子構造を近似的に特定する方法及びプログラム |
| JP2018169280A (ja) * | 2017-03-29 | 2018-11-01 | 一般財団法人石油エネルギー技術センター | 多成分混合物の分子構造を近似的に特定する方法及びプログラム(csa1) |
| US11275053B2 (en) | 2017-03-29 | 2022-03-15 | Japan Petroleum Energy Center | Method and program for approximately identifying molecular structure of multicomponent mixture |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010019848A (ja) | 2010-01-28 |
| NO20043943L (no) | 2004-09-21 |
| US7196323B2 (en) | 2007-03-27 |
| EP1481416A1 (de) | 2004-12-01 |
| CA2476597A1 (en) | 2003-09-04 |
| ES2590759T3 (es) | 2016-11-23 |
| IL163290A (en) | 2014-01-30 |
| EP1481416B1 (de) | 2016-06-15 |
| JP2005526962A (ja) | 2005-09-08 |
| AU2003218649A1 (en) | 2003-09-09 |
| US20050103991A1 (en) | 2005-05-19 |
| WO2003073464A1 (de) | 2003-09-04 |
| AU2003218649B2 (en) | 2007-09-06 |
| CA2476597C (en) | 2011-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2476597C (en) | Mass spectrometry method for analysing mixtures of substances | |
| Van Berkel et al. | Established and emerging atmospheric pressure surface sampling/ionization techniques for mass spectrometry | |
| CN103268851B (zh) | 热电离飞行时间质谱仪及热电离飞行时间质谱分析方法 | |
| US7078679B2 (en) | Inductive detection for mass spectrometry | |
| Chipuk et al. | Transmission mode desorption electrospray ionization | |
| Dunn | Mass spectrometry in systems biology: An introduction | |
| US7858928B2 (en) | Nanostructured surfaces as a dual ionization LDI-DESI platform for increased peptide coverage in proteomic analysis | |
| US7855357B2 (en) | Apparatus and method for ion calibrant introduction | |
| Chaudhary et al. | LC-MS/MS: a powerful tool for modern analytical science: Fundamentals, techniques, applications and innovations | |
| SOMOGYI | Mass spectrometry instrumentation and techniques | |
| Caixach et al. | Liquid chromatography–mass spectrometry | |
| Murray | Glossary of terms for separations coupled to mass spectrometry | |
| Henion et al. | Recent developments in electrospray mass spectrometry including implementation on an ion trap | |
| JP5219274B2 (ja) | 質量分析計 | |
| CN111624284B (zh) | 一种测定大黄醛中杂质丹蒽醌和大黄素的分析方法 | |
| Schmitz | State of the Art in the LC/MS | |
| Biddlecombe et al. | Mass spectrometry and quantitative bioanalysis | |
| Agarwal et al. | Ionization sources used in mass spectroscopy: a review | |
| CN120656925A (zh) | 一种双飞行时间二维快速分离的化学电离质谱仪及其同分异构体分离检测方法 | |
| Williams | Fundamentals of mass spectrometry | |
| Cowan et al. | Mass spectrometry in drug metabolism | |
| Vékey et al. | Mass spectrometry instrumentation and techniques | |
| Brown | Field asymmetric waveform ion mobility spectrometry-mass spectrometry studies of peptides and proteins | |
| Wood | Analysis of phenolic compounds with mass spectrometry | |
| Chernushevich et al. | Stable Isotope Ratio |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD01 | Notification of change of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7426 Effective date: 20131121 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140212 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140502 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140509 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140812 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20141111 |